MVIS vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

MVIS

39.2
AI Score
VS
MVIS Wins

CLOV

34.3
AI Score

Investment Advisor Scores

MVIS

39score
Recommendation
SELL

CLOV

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MVIS CLOV Winner
Revenue 2.41M 1.49B CLOV
Net Income -62.24M 55.34M CLOV
Net Margin -2584.6% 3.7% CLOV
Operating Income -47.70M 55.34M CLOV
ROE -301.8% 14.7% CLOV
ROA -70.2% 7.7% CLOV
Total Assets 88.61M 720.33M CLOV
Current Ratio 0.68 1.50 CLOV
Free Cash Flow -36.04M 131.55M CLOV

Relative Price Performance (Last 90 Days)

MVIS 1M: +503.0% · 3M: +176.2% CLOV 1M: -8.8% · 3M: +15.3%

Current Technical Phase

MVIS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $1.66

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $4.15

Fundamentals Snapshot

Metric MVIS CLOV
Market Cap
Forward P/E -9.8 27.7
Trailing P/E
Revenue (TTM)
Revenue Growth 8.5% 0.6%
Gross Margin -5.5% 0.2%
Operating Margin -14.9% 0.0%
EPS -5.49 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MVIS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.